Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Current Parent Company Summary

Current Parent Company Name: GlaxoSmithKline
Ownership Structure: publicly traded (ticker symbol LSE: GSK)
Headquartered in: United Kingdom
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $9,572,803,406
Number of records: 50
Top 5 Offense Groups (Groups Defined) Penalty Total Number of Records
financial offenses $3,400,000,000 1
healthcare-related offenses $3,019,361,860 5
safety-related offenses $1,782,642,648 9
competition-related offenses $1,056,270,000 17
government-contracting-related offenses $313,656,216 11
Top 5 Primary Offense Types Penalty Total Number of Records
tax violations $3,400,000,000 1
off-label or unapproved promotion of medical products $3,019,361,860 5
drug or medical equipment safety violation $1,782,583,148 8
price-fixing or anti-competitive practices $931,270,000 15
False Claims Act and related $313,656,216 11
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

Individual Penalty Records:

Click on the company or penalty amount for more information on each case.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
Company Primary Offense Type Year Agency Penalty Amount sort icon
GlaxoSmithKline Holdings (Americas) tax violations 2006 IRS $3,400,000,000
GlaxoSmithKline LLC off-label or unapproved promotion of medical products 2012 FDA $3,000,000,000
GlaxoSmithKline drug or medical equipment safety violation 2010 private lawsuit-federal $770,000,000
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 FDA $750,000,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2012 MULTI-AG (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
GlaxoSmithKline price-fixing or anti-competitive practices 2004 private lawsuit-federal $175,000,000
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 MULTI-AG (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000
GlaxoSmithKline False Claims Act and related 2005 DOJ_CIVIL $150,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2013 private lawsuit-federal $150,000,000
GlaxoSmithKline, LLC kickbacks and bribery 2014 MULTI-AG $105,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2005 private lawsuit-federal $100,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2004 private lawsuit-federal $92,000,000
GlaxoSmithKline LLC drug or medical equipment safety violation 2012 MULTI-AG $90,000,000
GlaxoSmithKline price-fixing or anti-competitive practices 2005 private lawsuit-federal $75,000,000
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $70,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2007 private lawsuit-federal $70,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2005 private lawsuit-federal $65,000,000
GlaxoSmithKline drug or medical equipment safety violation 2006 private lawsuit-state $63,833,148
GlaxoSmithKline LLC False Claims Act and related 2019 IL-AG $54,653,931
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2011 private lawsuit-federal $49,000,000
SmithKline Beecham False Claims Act and related 2003 DOJ_CIVIL $47,000,000
GlaxoSmithKline, LLC drug or medical equipment safety violation 2011 MULTI-AG $40,750,000
GlaxoSmithKline False Claims Act and related 2003 MULTI-AG $40,000,000
GlaxoSmithKline drug or medical equipment safety violation 2008 private lawsuit-federal $40,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2013 private lawsuit-federal $35,000,000
GlaxoSmithKline drug or medical equipment safety violation 2009 private lawsuit-federal $28,000,000
GlaxoSmithKline PLC price-fixing or anti-competitive practices 2013 private lawsuit-federal $21,500,000
GlaxoSmithKline plc kickbacks and bribery 2016 SEC $20,000,000
GlaxoSmithKline, LLC off-label or unapproved promotion of medical products 2013 MD-AG $15,000,000
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $14,000,000
GlaxoSmithKline False Claims Act and related 2005 MULTI-AG (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000
GlaxoSmithKline False Claims Act and related 2012 LA-AG $10,000,000
SmithKline Beecham Corp. price-fixing or anti-competitive practices 2005 MULTI-AG $10,000,000
GlaxoSmithKline False Claims Act and related 2011 KS-AG $4,250,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2010 KY-AG $3,700,000
GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $3,500,000
GlaxoSmithKline LLC False Claims Act and related 2010 HI-AG $3,333,333
GlaxoSmithKline False Claims Act and related 2012 ID-AG $2,600,000
SmithKline Beecham Corp. False Claims Act and related 2007 TX-AG $1,400,000
GlaxoSmithKline price-fixing or anti-competitive practices 2023 IN-AG $1,270,000
GlaxoSmithKline off-label or unapproved promotion of medical products 2009 KY-AG $661,860
GlaxoSmithKline False Claims Act and related 2006 GA-AG $418,952
Block Drug Company Incorporated wage and hour violation 2011 WHD $352,773
GlaxoSmithKline LLC environmental violation 2014 EPA $317,550
GLAXOSMITHKLINE, LLC environmental violation 2014 EPA (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550
GlaxoSmithKline Vaccines environmental violation 2014 EPA $172,900
GLAXOSMITHKLINE VACCINES environmental violation 2014 EPA (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900
GLAXO SMITH KLINE aviation safety violation 2014 FAA $59,500
GlaxoSmithKline LLC environmental violation 2015 NY-ENV $24,200
GLAXOSMITHKLINE LLC environmental violation 2016 PA-ENV $5,259
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.